In non-Hodgkin lymphoma, there are no Reed-Sternberg cells present. Rarely, leukemia can transform into lymphoma, usually non-Hodgkin lymphoma. This is called Richter's syndrome. Richter's syndrome ...

Several nonprofit organizations, such as the American Cancer Society, Cancer Care, CLL Society, and the Leukemia and Lymphoma Society provide ways for people with CLL to connect with others.

Rarely, leukemia can transform into lymphoma, usually non-Hodgkin lymphoma. This is called Richter's syndrome. Richter's syndrome tends to happen with chronic lymphocytic leukemia (CLL).

During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed the data supporting the 2 newer BTK ...

In an interview, Paolo Ghia, MD, PhD, discussed updated data from the phase 2 CAPTIVATE trial of ibrutinib and venetoclax in ...

From the deaths of John Sykes and former Planned Parenthood President Cecile Richards to an update from Mike Peters, here’s ...

Brukinsa had a lower risk of disease progression or death versus Imbruvica, as well as a more favorable safety profile, in R/R CLL and SLL.

Signs and symptoms of acute lymphocytic leukemia (ALL). John Hopkins Medicine. Chronic lymphocytic leukemia (CLL) diagnosis. Memorial Sloan Kettering Cancer Center. Risk factors for leukemia. Karen ...

Panelists discuss how challenges in implementing emerging Bruton tyrosine kinase inhibitor (BTKi) regimens for ...

This leads to conditions such as anemia, increased susceptibility to infections, and impaired clotting. Approximately 5% to 10% of patients with CLL present with B-symptoms, which are associated with ...

TBI remained significantly associated with reduced adjusted risks of grade 3 to 4 aGVHD and moderate-severe cGVHD.